Rchr
J-GLOBAL ID：201601013751019694   Update date: Dec. 10, 2024

Ochi Toshiki

オチ トシキ | Ochi Toshiki
Affiliation and department：
Ehime University Graduate School of Medicine Department of Hematology, Clinical Immunology and Infectious Diseases

About Ehime University Graduate School of Medicine Department of Hematology, Clinical Immunology and Infectious Diseases


Other affiliations (1)：
  • Ehime University  Division of Immune Regulation, Proteo - Science Center 
Research field  (2)： Hematology and oncology ,  Immunology
Research theme for competitive and other funds  (24)：
  • 2024 - 2027 新たなT細胞活性化シグナルに基づく新規キメラ抗原受容体の開発研究
  • 2024 - 2025 新規抗体産生プラットフォームの樹立とその応用
  • 2022 - 2025 Development of multifunctional CAR-T cell therapy using novel manufacturing technology of scFv
  • 2023 - 2024 免疫療法の効果を高めるuniversal抗体の開発
  • 2023 - 2024 有効性と安全性を両立する新規キメラ抗原受容体遺伝子の開発とがん治療への応用
Show all
Papers (51)：
ｍore...
MISC (104)：
ｍore...
Patents (6)：
ｍore...
Books (4)：
  • 血液疾患最新の治療
    南江堂 2019 ISBN:9784524260713
  • がん免疫療法の個別化を支える新・腫瘍免疫学
    羊土社 2019 ISBN:9784758103817
  • 血液フロンティア
    医薬ジャーナル社 2018
  • 血液フロンティア
    医薬ジャーナル社 2016
Lectures and oral presentations  (46)：
  • Different functionality of CD19 CAR-T cells after stimulation with various amounts of tumor cells.
    (The 86th JSH Annual Meeting 2024)
  • T-Cell Redirection Therapy with Talented Antibodies for Hematological Malignancies.
    (The 83rd Annual Meeting of the Japanese Cancer Association 2024)
  • Fine-tuned scFvs and optimized CAR-T cells -From a translational technology to the CAR-T discovery-
    (2024)
  • Suboptimal characteristics of CD19 CAR-T cells stimulated with high amounts of tumors.
    (2024)
  • Conventional CD19 CAR-T cells stimulated with high amounts of tumors show suboptimal functionality.
    (The 28th Annual Meeting of Japanese Association of Cancer Immunotherapy 2024)
ｍore...
Professional career (1)：
  • 医学博士 (愛媛大学)
Work history (9)：
  • 2022/07 - 現在 Ehime University Graduate School of Medicine Department of Hematology, Clinical Immunology and Infectious Diseases
  • 2020/07 - 現在 Optieum Biotechnologies Inc.
  • 2018/04 - 現在 Proteo - Science Center, Ehime University Division of Immune Regulation
  • 2016/04 - 2022/12 Ehime University Graduate School of Medicine Department of Hematology, Clinical Immunology and Infectious Diseases
  • 2011/09 - 2016/03 Princess Margaret Cancer Centre, University Health Network Tumor Immunotherapy Program Postdoctoral Fellow
Show all
Committee career (3)：
  • 2021/11 - 現在 日本がん免疫学会 評議員
  • 2019/09 - 現在 日本血液学会 評議員
  • 2017/10 - 現在 日本血液疾患免疫療法学会 評議員
Awards (6)：
  • 2016/05 - 7th JSH international symposium Best Oral Presentation Award
  • 2014/05 - University Health Network ORT Conference Travel Award
  • 2013/10 - OCI/PM Guglietti Immune Therapy Fellowship Award
  • 2011/12 - Abstract Achievement Award, 53rd annual meeting of American Society of Hematology
  • 2010/03 - 愛媛大学大学院医学系研究科 研究奨励賞
Show all
Association Membership(s) (8)：
日本輸血・細胞治療学会 ,  日本造血・免疫細胞療法学会 ,  日本臨床分子医学会 ,  日本骨髄腫学会 ,  日本血液疾患免疫療法学会 ,  日本がん免疫学会 ,  日本血液学会 ,  日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM